Peripapillary Intravitreal Injection Improves AAV-Mediated Retinal Transduction
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 17, 647-656
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning (2019R1A2C1005055)
- Ministry of Health and Welfare (HI17C0966)
This publication has 64 references indexed in Scilit:
- Immunology of AAV-Mediated Gene Transfer in the EyeFrontiers in Immunology, 2013
- Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 MutationsArchives of Ophthalmology (1950), 2012
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular DegenerationMolecular Therapy, 2011
- Transduction of the inner mouse retina using AAVrh8 and AAVrh10 via intravitreal injectionExperimental Eye Research, 2010
- EXPERIMENTAL MODEL OF INTRAVITREAL INJECTION TECHNIQUESRetina, 2010
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the VitreousMolecular Therapy, 2009
- A Novel Adeno-Associated Viral Variant for Efficient and Selective Intravitreal Transduction of Rat Müller CellsPLOS ONE, 2009
- Efficiency and Safety of AAV-Mediated Gene Delivery of the Human ND4 Complex I Subunit in the Mouse Visual SystemInvestigative Ophthalmology & Visual Science, 2009
- Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kineticsProceedings of the National Academy of Sciences, 2008
- Long-Term Protection of Retinal Structure but Not Function Using RAAV.CNTF in Animal Models of Retinitis PigmentosaMolecular Therapy, 2001